Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

The use of lexipafant in the treatment of acute pancreatitis.

McKay C, Curran FJ, Sharples CE, Young CA, Baxter JN, Imrie CW.

Adv Exp Med Biol. 1996;416:365-70. Review.

PMID:
9131175
2.

Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis.

Johnson CD, Kingsnorth AN, Imrie CW, McMahon MJ, Neoptolemos JP, McKay C, Toh SK, Skaife P, Leeder PC, Wilson P, Larvin M, Curtis LD.

Gut. 2001 Jan;48(1):62-9.

3.

Platelet-activating factor.

Kingsnorth AN.

Scand J Gastroenterol Suppl. 1996;219:28-31. Review.

PMID:
8865468
4.

Lexipafant and acute pancreatitis: a critical appraisal of the clinical trials.

Abu-Zidan FM, Windsor JA.

Eur J Surg. 2002;168(4):215-9. Review.

PMID:
12440758
5.

Platelet activating factor antagonism reduces the systemic inflammatory response in a murine model of acute pancreatitis.

Lane JS, Todd KE, Gloor B, Chandler CF, Kau AW, Ashley SW, Reber HA, McFadden DW.

J Surg Res. 2001 Aug;99(2):365-70.

PMID:
11469912
6.

[New aspects of pharmaco-therapy for acute pancreatitis].

Takase K, Ueda T, Kuroda Y.

Nihon Rinsho. 2004 Nov;62(11):2074-8. Review. Japanese.

PMID:
15552891
7.

The scientific basis of medical therapy of acute pancreatitis. Could it work, and is there a role for lexipafant?

Imrie CW, McKay CJ.

Gastroenterol Clin North Am. 1999 Sep;28(3):591-9, ix. Review.

PMID:
10503138
8.

Treatment with lexipafant ameliorates the severity of pancreatic microvascular endothelial barrier dysfunction in rats with acute hemorrhagic pancreatitis.

Wang X, Sun Z, Börjesson A, Haraldsen P, Aldman M, Deng X, Leveau P, Andersson R.

Int J Pancreatol. 1999 Feb;25(1):45-52.

PMID:
10211421
9.

Effect of a platelet-activating factor antagonist on pancreatitis-associated gut barrier dysfunction in rats.

Andersson R, Wang X, Sun Z, Deng X, Soltesz V, Ihse I.

Pancreas. 1998 Aug;17(2):107-19.

PMID:
9700940
10.

Severity of pancreatitis-associated gut barrier dysfunction is reduced following treatment with the PAF inhibitor lexipafant.

Leveau P, Wang X, Sun Z, Börjesson A, Andersson E, Andersson R.

Biochem Pharmacol. 2005 May 1;69(9):1325-31.

PMID:
15826603
11.

Lexipafant in severe acute pancreatitis: the final word?

Ulrich CD 2nd.

Curr Gastroenterol Rep. 2001 Apr;3(2):85-7. Review. No abstract available.

PMID:
11276374
12.
13.

Hope or hype for lexipafant?

Abu-Zidan FM.

Nature. 1998 Oct 1;395(6701):431. No abstract available.

PMID:
9774090
14.

Lexipafant (BB-882), a potent PAF antagonist in acute pancreatitis.

Curtis LD.

Adv Exp Med Biol. 1996;416:361-3. Review. No abstract available.

PMID:
9131174
15.

Prospective placebo-controlled randomized trial of lexipafant in predicted severe acute pancreatitis.

McKay CJ, Curran F, Sharples C, Baxter JN, Imrie CW.

Br J Surg. 1997 Sep;84(9):1239-43.

PMID:
9313702
16.

Cytokines and acute pancreatitis.

Brady M, Christmas S, Sutton R, Neoptolemos J, Slavin J.

Baillieres Best Pract Res Clin Gastroenterol. 1999 Jul;13(2):265-89. Review.

PMID:
11030606
17.

The possible role of platelet-activating factor antagonist therapy in the management of severe acute pancreatitis.

Imrie CW, McKay CJ.

Baillieres Best Pract Res Clin Gastroenterol. 1999 Jul;13(2):357-64. Review.

PMID:
11030612
18.

Prospective placebo-controlled randomized trial of lexipafant in predicted severe acute pancreatitis.

Wyncoll DL, Beale RJ.

Br J Surg. 1998 Feb;85(2):279-80. No abstract available.

PMID:
9501837
19.

Lexipafant fails to improve survival in severe necrotizing pancreatitis in rats.

Rivera JA, Werner J, Warshaw AL, Lewandrowski KB, Rattner DW, Fernández del Castillo C.

Int J Pancreatol. 1998 Apr;23(2):101-6.

PMID:
9629507
20.

[Conservative treatment of acute pancreatitis].

Mayerle J, Simon P, Kraft M, Meister T, Lerch MM.

Med Klin (Munich). 2003 Dec 15;98(12):744-9. Review. German.

PMID:
14685675
Items per page

Supplemental Content

Write to the Help Desk